Jan Müller‐Brand

5.0k total citations · 1 hit paper
101 papers, 3.5k citations indexed

About

Jan Müller‐Brand is a scholar working on Radiology, Nuclear Medicine and Imaging, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jan Müller‐Brand has authored 101 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Radiology, Nuclear Medicine and Imaging, 24 papers in Epidemiology and 24 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jan Müller‐Brand's work include Neuroendocrine Tumor Research Advances (21 papers), Cardiac Imaging and Diagnostics (20 papers) and Thyroid Cancer Diagnosis and Treatment (20 papers). Jan Müller‐Brand is often cited by papers focused on Neuroendocrine Tumor Research Advances (21 papers), Cardiac Imaging and Diagnostics (20 papers) and Thyroid Cancer Diagnosis and Treatment (20 papers). Jan Müller‐Brand collaborates with scholars based in Switzerland, Chile and United States. Jan Müller‐Brand's co-authors include Martin A. Walter, Helmut R. Mäcke, Matthias Briel, Christoph Rochlitz, Helmut Rasch, Philippe Brunner, Nicolas Marincek, Christian Schindler, Beat P. Müller‐Stich and Matthias Pfisterer and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Jan Müller‐Brand

95 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [⁹⁰Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers

2011 452 citations Philippe Brunner, Nicolas Marincek et al. profile →

Peers

Countries citing papers authored by Jan Müller‐Brand

Since Specialization

Citations

This map shows the geographic impact of Jan Müller‐Brand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Müller‐Brand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Müller‐Brand more than expected).

Fields of papers citing papers by Jan Müller‐Brand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Müller‐Brand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Müller‐Brand. The network helps show where Jan Müller‐Brand may publish in the future.

Co-authorship network of co-authors of Jan Müller‐Brand

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Müller‐Brand. A scholar is included among the top collaborators of Jan Müller‐Brand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Müller‐Brand. Jan Müller‐Brand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic value of myocardial perfusion imaging in asymptomatic high-risk diabetic patients: 10-year follow-up of the prospective multicentre BARDOT trial 2025 ·European Heart Journal - Cardiovascular Imaging ·(unknown), (unknown), (unknown), Damian Wild, Philip Haaf, Felix Mahfoud, Michael J. Zellweger, (unknown), Jan Müller‐Brand, Miriam Brinkert, Thilo Burkard, Federico Caobelli, Stefanie von Felten, (unknown), Raban Jeger, Ulrich Keller, (unknown), Hans H. Osterhues, Otmar Pfister, Matthias Pfisterer, (unknown)	0
2	Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus 2017 ·International Journal of Cardiology ·Michael J. Zellweger, Philip Haaf, (unknown), Hans H. Osterhues, Ulrich Keller, Jan Müller‐Brand, Raban Jeger, Otmar Pfister, Miriam Brinkert, Thilo Burkard, Matthias Pfisterer	28
3	Towards tailored radiopeptide therapy 2015 ·European Journal of Nuclear Medicine and Molecular Imaging ·Piotr Radojewski, Rebecca A. Dumont, Nicolas Marincek, Philippe Brunner, Helmut R. Mäcke, Jan Müller‐Brand, Matthias Briel, Martin A. Walter	14
4	Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study 2013 ·Journal of Translational Medicine ·Nicolas Marincek, (unknown), Philippe Brunner, Christian Schindler, Michael Koller, Christoph Rochlitz, Jan Müller‐Brand, Helmut R. Maëcke, Matthias Briel, Martin A. Walter	21
5	Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours 2013 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), Nicolas Marincek, Philippe Brunner, Michael Koller, (unknown), Helmut R. Maëcke, Jan Müller‐Brand, Christoph Rochlitz, Matthias Briel, Christian Schindler, Martin A. Walter	61
6	Peptide Receptor Radionuclide Therapy with <sup>90</sup>Y-DOTATOC and <sup>177</sup>Lu-DOTATOC in Advanced Neuroendocrine Tumors: Results from a Danish Cohort Treated in Switzerland 2011 ·Neuroendocrinology ·(unknown), Tine Gregersen, Henning Grønbæk, Carsten Palnæs Hansen, Jan Müller‐Brand, (unknown), Klaus Krogh, Andreas Kjær, Ulrich Knigge	96
7	Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA–substance P—results from a phase I study 2010 ·Journal of Neuro-Oncology ·Dominik Cordier, Flavio Forrer, Stefan Kneifel, Martin Sailer, Luigi Mariani, Helmut R. Mäcke, Jan Müller‐Brand, Adrian Merlo	46
8	Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours 2008 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Martin A. Walter, Beatrice Waser, Xuejuan Wang, Jan Müller‐Brand, Martin Béhé, Jean–Claude Reubi, Helmut R. Maëcke	81
9	The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study 2007 ·Journal of Nuclear Medicine ·Martin A. Walter, Christian P. Turtschi, Christian Schindler, (unknown), Jan Müller‐Brand, Beat P. Müller‐Stich	57
10	Outcome of radioiodine therapy without, on or 3 days off carbimazole: a prospective interventional three-group comparison 2006 ·European Journal of Nuclear Medicine and Molecular Imaging ·Martin A. Walter, Mirjam Christ‐Crain, Christian Schindler, Jan Müller‐Brand, Beat P. Müller‐Stich	34
11	Three‐year recurrence‐free survival in a patient with recurrent medulloblastoma after resection, high‐dose chemotherapy, and intrathecal Yttrium‐90‐labeled DOTA⁰‐D‐Phe¹‐Tyr³‐octreotide radiopeptide brachytherapy 2005 ·Cancer ·(unknown), (unknown), Jean–Claude Reubi, Helmut R. Mäcke, Jan Müller‐Brand, Adrian Merlo, Thomas Kühne	20
12	Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post‐therapeutic outcome 2004 ·European Journal of Clinical Investigation ·Martin A. Walter, Mirjam Christ‐Crain, (unknown), Christian Schindler, Egbert Nitzsche, Jan Müller‐Brand, Beat P. Müller‐Stich	34
13	Evidence for left ventricular remodeling after percutaneous coronary intervention 2003 ·International Journal of Cardiology ·Michael J. Zellweger, (unknown), Andreas Zutter, M. Weinbacher, (unknown), Jan Müller‐Brand, Matthias Pfisterer	11
14	Prospective Evaluation of an Algorithm for the Functional Assessment of Lung Resection Candidates 1999 ·American Journal of Respiratory and Critical Care Medicine ·C Wyser, P Stulz, Markus Solèr, Michael Tamm, Jan Müller‐Brand, James Habicht, André P. Perruchoud, Chris T. Bolliger	107
15	Improved myocardial ischemia detection by combined physical and mental stress testing 1998 ·The American Journal of Cardiology ·(unknown), (unknown), Jan Müller‐Brand, Peter Buser, Matthias Pfisterer	10
16	Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium 1997 ·Nephrology Dialysis Transplantation ·A Blumberg, H.W. Roser, C Zehnder, Jan Müller‐Brand	86
17	Evaluation of High-Risk Lung Resection Candidates: Pulmonary Haemodynamics versus Exercise Testing 1994 ·Respiration ·Chris T. Bolliger, M. Solèr, P Stulz, Erich Grädel, Jan Müller‐Brand, S Elsässer, (unknown), C Wyser, (unknown)	32
18	Prevention of aortocoronary vein bypass graft occlusion: Which antithrombotic treatment and for how long? 1990 ·Thrombosis Research ·M. Pfisterer, F Burkart, (unknown), (unknown), Stephan Regenass, D Burckhardt, Henri Schmitt, Jan Müller‐Brand, K. Skarvan, P Stulz, J. Hasse, Erich Grädel	2
19	Prevalence and extent of right ventricular dysfunction after myocardial infarction — relation to location and extent of infarction and left ventricular function 1990 ·International Journal of Cardiology ·Matthias Pfisterer, (unknown), Jan Müller‐Brand, F Burkart	15
20	Important differences between short- and long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction 1985 ·Journal of the American College of Cardiology ·Matthias Pfisterer, F Burkart, Jan Müller‐Brand, Wolfgang Kiowski	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact